 | • レポートコード：MRC2102QY5010 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の勃起不全薬市場について種類別（シルデナフィル、タダラフィル、その他）、用途別（病院薬局、民間クリニック、小売薬局、Eコマース（B2B）、Eコマース（B2C））、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・勃起不全薬市場の概要 ・世界の主要地域別勃起不全薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の勃起不全薬市場規模2015-2026：種類別（シルデナフィル、タダラフィル、その他） ・世界の勃起不全薬市場規模2015-2026：用途別（病院薬局、民間クリニック、小売薬局、Eコマース（B2B）、Eコマース（B2C）） ・勃起不全薬の米国市場規模2015-2020 ・勃起不全薬のヨーロッパ市場規模2015-2020 ・勃起不全薬の中国市場規模2015-2020 ・勃起不全薬の日本市場規模2015-2020 ・勃起不全薬の東南アジア市場規模2015-2020 ・勃起不全薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・勃起不全薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・勃起不全薬の市場動向・機会・課題 ・調査の結論 |
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The classification of Erectile Dysfunction Drugs includes Sildenafil, Tadalafil and others, and the proportion of Sildenafil in 2018 is about 99.85%, and the proportion is in decreasing trend from 2014 to 2018.Erectile Dysfunction Drugs is widely used through Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B) and E-Commerce (B2C). The most proportion of Erectile Dysfunction Drugs is used for Hospital Pharmacies, and the sales proportion in 2018 is 29.24%.North America is the largest consumption place, with a consumption market share nearly 39.05% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 30.52%. Despite of increasing demand for erectile dysfunction drugs, this market is going to experience a decline in forecast period due to patent expiration of major brands. On the contrary, it will provide the key opportunity for generic manufacturers to enter the market. Generic drugs are the promising opportunity for this market.
Market Analysis and Insights: Global Erectile Dysfunction Drugs Market
The global Erectile Dysfunction Drugs market size is projected to reach US$ 8119.6 million by 2026, from US$ 5724 million in 2020, at a CAGR of 6.0% during 2021-2026.
Global Erectile Dysfunction Drugs Scope and Market Size
The global Erectile Dysfunction Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Erectile Dysfunction Drugs market is segmented into
Sildenafil
Tadalafil
Others
In 2018, Sildenafil accounted for a major share of 56% in the global Erectile Dysfunction Drugs market. And this product segment is poised to reach 3366.84 M USD by 2025 from 2483.77 M USD in 2019.
Segment by Application, the Erectile Dysfunction Drugs market is segmented into
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
In Erectile Dysfunction Drugs market, Hospital Pharmacies segment holds an important share in terms of application, and it is expected to reach a volume of 458.57 (M Pill) by 2025, at a CAGR of 12.63% during 2018 and 2025. It means that Erectile Dysfunction Drugs will be promising in the Hospital Pharmacies field in the next couple of years.
The Erectile Dysfunction Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Erectile Dysfunction Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Erectile Dysfunction Drugs Market Share Analysis
Erectile Dysfunction Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Erectile Dysfunction Drugs business, the date to enter into the Erectile Dysfunction Drugs market, Erectile Dysfunction Drugs product introduction, recent developments, etc.
The major vendors covered:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
1 Erectile Dysfunction Drugs Market Overview
1.1 Erectile Dysfunction Drugs Product Scope
1.2 Erectile Dysfunction Drugs Segment by Type
1.2.1 Global Erectile Dysfunction Drugs Sales by Type (2020-2026)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Drugs Segment by Application
1.3.1 Global Erectile Dysfunction Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Erectile Dysfunction Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Erectile Dysfunction Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Erectile Dysfunction Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Erectile Dysfunction Drugs Price Trends (2015-2026)
2 Erectile Dysfunction Drugs Estimate and Forecast by Region
2.1 Global Erectile Dysfunction Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Erectile Dysfunction Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Erectile Dysfunction Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Erectile Dysfunction Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Erectile Dysfunction Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Erectile Dysfunction Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Erectile Dysfunction Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Erectile Dysfunction Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Erectile Dysfunction Drugs Estimates and Projections (2015-2026)
2.4.3 China Erectile Dysfunction Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Erectile Dysfunction Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Erectile Dysfunction Drugs Estimates and Projections (2015-2026)
2.4.6 India Erectile Dysfunction Drugs Estimates and Projections (2015-2026)
3 Global Erectile Dysfunction Drugs Competition Landscape by Players
3.1 Global Top Erectile Dysfunction Drugs Players by Sales (2015-2020)
3.2 Global Top Erectile Dysfunction Drugs Players by Revenue (2015-2020)
3.3 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction Drugs as of 2019)
3.4 Global Erectile Dysfunction Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Erectile Dysfunction Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Erectile Dysfunction Drugs Players (Opinion Leaders)
4 Global Erectile Dysfunction Drugs Market Size by Type
4.1 Global Erectile Dysfunction Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Erectile Dysfunction Drugs Price by Type (2015-2020)
4.2 Global Erectile Dysfunction Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Erectile Dysfunction Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Erectile Dysfunction Drugs Price Forecast by Type (2021-2026)
5 Global Erectile Dysfunction Drugs Market Size by Application
5.1 Global Erectile Dysfunction Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Erectile Dysfunction Drugs Price by Application (2015-2020)
5.2 Global Erectile Dysfunction Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Erectile Dysfunction Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Erectile Dysfunction Drugs Price Forecast by Application (2021-2026)
6 United States Erectile Dysfunction Drugs Market Facts & Figures
6.1 United States Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
6.2 United States Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
6.3 United States Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
7 Europe Erectile Dysfunction Drugs Market Facts & Figures
7.1 Europe Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
8 China Erectile Dysfunction Drugs Market Facts & Figures
8.1 China Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
8.2 China Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
8.3 China Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
9 Japan Erectile Dysfunction Drugs Market Facts & Figures
9.1 Japan Erectile Dysfunction Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Erectile Dysfunction Drugs Market Facts & Figures
10.1 Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
11 India Erectile Dysfunction Drugs Market Facts & Figures
11.1 India Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
11.2 India Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
11.3 India Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Erectile Dysfunction Drugs Business
12.1 Eli Lilly
12.1.1 Eli Lilly Corporation Information
12.1.2 Eli Lilly Business Overview
12.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Eli Lilly Erectile Dysfunction Drugs Products Offered
12.1.5 Eli Lilly Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Erectile Dysfunction Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer Erectile Dysfunction Drugs Products Offered
12.3.5 Bayer Recent Development
12.4 BaiYunShan General Factory
12.4.1 BaiYunShan General Factory Corporation Information
12.4.2 BaiYunShan General Factory Business Overview
12.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Products Offered
12.4.5 BaiYunShan General Factory Recent Development
12.5 S.K. Chemicals
12.5.1 S.K. Chemicals Corporation Information
12.5.2 S.K. Chemicals Business Overview
12.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 S.K. Chemicals Erectile Dysfunction Drugs Products Offered
12.5.5 S.K. Chemicals Recent Development
12.6 Teva Pharma
12.6.1 Teva Pharma Corporation Information
12.6.2 Teva Pharma Business Overview
12.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teva Pharma Erectile Dysfunction Drugs Products Offered
12.6.5 Teva Pharma Recent Development
12.7 Dong-A ST
12.7.1 Dong-A ST Corporation Information
12.7.2 Dong-A ST Business Overview
12.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Dong-A ST Erectile Dysfunction Drugs Products Offered
12.7.5 Dong-A ST Recent Development
12.8 Metuchen Pharma
12.8.1 Metuchen Pharma Corporation Information
12.8.2 Metuchen Pharma Business Overview
12.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Metuchen Pharma Erectile Dysfunction Drugs Products Offered
12.8.5 Metuchen Pharma Recent Development
12.9 Seoul Pharma
12.9.1 Seoul Pharma Corporation Information
12.9.2 Seoul Pharma Business Overview
12.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Seoul Pharma Erectile Dysfunction Drugs Products Offered
12.9.5 Seoul Pharma Recent Development
12.10 CSBIO.
12.10.1 CSBIO. Corporation Information
12.10.2 CSBIO. Business Overview
12.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CSBIO. Erectile Dysfunction Drugs Products Offered
12.10.5 CSBIO. Recent Development
13 Erectile Dysfunction Drugs Manufacturing Cost Analysis
13.1 Erectile Dysfunction Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Erectile Dysfunction Drugs
13.4 Erectile Dysfunction Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Erectile Dysfunction Drugs Distributors List
14.3 Erectile Dysfunction Drugs Customers
15 Market Dynamics
15.1 Erectile Dysfunction Drugs Market Trends
15.2 Erectile Dysfunction Drugs Opportunities and Drivers
15.3 Erectile Dysfunction Drugs Market Challenges
15.4 Erectile Dysfunction Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Erectile Dysfunction Drugs Sales (M Pill) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Erectile Dysfunction Drugs Sales (M Pill) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Erectile Dysfunction Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Erectile Dysfunction Drugs Sales (M Pill) by Region (2015-2020)
Table 5. Global Erectile Dysfunction Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Erectile Dysfunction Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Erectile Dysfunction Drugs Revenue Share by Region (2015-2020)
Table 8. Global Erectile Dysfunction Drugs Sales (M Pill) Forecast by Region (2021-2026)
Table 9. Global Erectile Dysfunction Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Erectile Dysfunction Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Erectile Dysfunction Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Erectile Dysfunction Drugs (M Pill) of Key Companies (2015-2020)
Table 13. Global Erectile Dysfunction Drugs Sales Share by Company (2015-2020)
Table 14. Global Erectile Dysfunction Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Erectile Dysfunction Drugs Revenue Share by Company (2015-2020)
Table 16. Global Erectile Dysfunction Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction Drugs as of 2019)
Table 17. Global Erectile Dysfunction Drugs Average Price (USD/Pill) of Key Company (2015-2020)
Table 18. Manufacturers Erectile Dysfunction Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Erectile Dysfunction Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Erectile Dysfunction Drugs Players
Table 22. Global Erectile Dysfunction Drugs Sales (M Pill) by Type (2015-2020)
Table 23. Global Erectile Dysfunction Drugs Sales Share by Type (2015-2020)
Table 24. Global Erectile Dysfunction Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Erectile Dysfunction Drugs Price (M Pill) by Type (2015-2020)
Table 26. Global Erectile Dysfunction Drugs Sales Share by Type (2021-2026)
Table 27. Global Erectile Dysfunction Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Erectile Dysfunction Drugs Revenue Share by Type (2021-2026)
Table 29. Global Erectile Dysfunction Drugs Price (M Pill) by Type (2021-2026)
Table 30. Global Erectile Dysfunction Drugs Sales (M Pill) by Application (2015-2020)
Table 31. Global Erectile Dysfunction Drugs Sales Share by Application (2015-2020)
Table 32. Global Erectile Dysfunction Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Erectile Dysfunction Drugs Price (M Pill) by Application (2015-2020)
Table 34. Global Erectile Dysfunction Drugs Sales (M Pill) by Application (2021-2026)
Table 35. Global Erectile Dysfunction Drugs Sales Share by Application (2021-2026)
Table 36. Global Erectile Dysfunction Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Erectile Dysfunction Drugs Revenue Share by Application (2021-2026)
Table 38. Global Erectile Dysfunction Drugs Price (M Pill) by Application (2021-2026)
Table 39. United States Erectile Dysfunction Drugs Sales (M Pill) by Company (2015-2020)
Table 40. United States Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Erectile Dysfunction Drugs Sales (M Pill) by Type (2015-2020)
Table 42. United States Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Erectile Dysfunction Drugs Sales (M Pill) by Application (2015-2020)
Table 44. United States Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Erectile Dysfunction Drugs Sales (M Pill) by Company (2015-2020)
Table 46. Europe Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Erectile Dysfunction Drugs Sales (M Pill) by Type (2015-2020)
Table 48. Europe Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Erectile Dysfunction Drugs Sales (M Pill) by Application (2015-2020)
Table 50. Europe Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
Table 51. China Erectile Dysfunction Drugs Sales (M Pill) by Company (2015-2020)
Table 52. China Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
Table 53. China Erectile Dysfunction Drugs Sales (M Pill) by Type (2015-2020)
Table 54. China Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
Table 55. China Erectile Dysfunction Drugs Sales (M Pill) by Application (2015-2020)
Table 56. China Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Erectile Dysfunction Drugs Sales (M Pill) by Company (2015-2020)
Table 58. Japan Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Erectile Dysfunction Drugs Sales (M Pill) by Type (2015-2020)
Table 60. Japan Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Erectile Dysfunction Drugs Sales (M Pill) by Application (2015-2020)
Table 62. Japan Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Erectile Dysfunction Drugs Sales (M Pill) by Company (2015-2020)
Table 64. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Erectile Dysfunction Drugs Sales (M Pill) by Type (2015-2020)
Table 66. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Erectile Dysfunction Drugs Sales (M Pill) by Type (2015-2020)
Table 68. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
Table 69. India Erectile Dysfunction Drugs Sales (M Pill) by Company (2015-2020)
Table 70. India Erectile Dysfunction Drugs Sales Market Share by Company (2015-2020)
Table 71. India Erectile Dysfunction Drugs Sales (M Pill) by Type (2015-2020)
Table 72. India Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
Table 73. India Erectile Dysfunction Drugs Sales (M Pill) by Application (2015-2020)
Table 74. India Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
Table 75. Eli Lilly Corporation Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2015-2020)
Table 78. Eli Lilly Erectile Dysfunction Drugs Product
Table 79. Eli Lilly Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2015-2020)
Table 83. Pfizer Erectile Dysfunction Drugs Product
Table 84. Pfizer Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2015-2020)
Table 88. Bayer Erectile Dysfunction Drugs Product
Table 89. Bayer Recent Development
Table 90. BaiYunShan General Factory Corporation Information
Table 91. BaiYunShan General Factory Description and Business Overview
Table 92. BaiYunShan General Factory Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2015-2020)
Table 93. BaiYunShan General Factory Erectile Dysfunction Drugs Product
Table 94. BaiYunShan General Factory Recent Development
Table 95. S.K. Chemicals Corporation Information
Table 96. S.K. Chemicals Description and Business Overview
Table 97. S.K. Chemicals Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2015-2020)
Table 98. S.K. Chemicals Erectile Dysfunction Drugs Product
Table 99. S.K. Chemicals Recent Development
Table 100. Teva Pharma Corporation Information
Table 101. Teva Pharma Description and Business Overview
Table 102. Teva Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2015-2020)
Table 103. Teva Pharma Erectile Dysfunction Drugs Product
Table 104. Teva Pharma Recent Development
Table 105. Dong-A ST Corporation Information
Table 106. Dong-A ST Description and Business Overview
Table 107. Dong-A ST Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2015-2020)
Table 108. Dong-A ST Erectile Dysfunction Drugs Product
Table 109. Dong-A ST Recent Development
Table 110. Metuchen Pharma Corporation Information
Table 111. Metuchen Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2015-2020)
Table 112. Metuchen Pharma Description and Business Overview
Table 113. Metuchen Pharma Erectile Dysfunction Drugs Product
Table 114. Metuchen Pharma Recent Development
Table 115. Seoul Pharma Corporation Information
Table 116. Seoul Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2015-2020)
Table 117. Seoul Pharma Description and Business Overview
Table 118. Seoul Pharma Erectile Dysfunction Drugs Product
Table 119. Seoul Pharma Recent Development
Table 120. CSBIO. Corporation Information
Table 121. CSBIO. Description and Business Overview
Table 122. CSBIO. Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2015-2020)
Table 123. CSBIO. Erectile Dysfunction Drugs Product
Table 124. CSBIO. Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Erectile Dysfunction Drugs Distributors List
Table 128. Erectile Dysfunction Drugs Customers List
Table 129. Erectile Dysfunction Drugs Market Key Trends
Table 130. Erectile Dysfunction Drugs Key Opportunities and Drivers
Table 131. Erectile Dysfunction Drugs Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Erectile Dysfunction Drugs Product Picture
Figure 2. Global Erectile Dysfunction Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Erectile Dysfunction Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Private Clinics Examples
Figure 8. Retail Pharmacies Examples
Figure 9. E-Commerce (B2B) Examples
Figure 10. E-Commerce (B2C) Examples
Figure 11. Global Erectile Dysfunction Drugs Sales (M Pill) Growth Rate (2015-2026)
Figure 12. Global Erectile Dysfunction Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Erectile Dysfunction Drugs Price Trends Growth Rate (2015-2026) (USD/Pill)
Figure 14. Global Erectile Dysfunction Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Erectile Dysfunction Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Erectile Dysfunction Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Erectile Dysfunction Drugs Sales (M Pill) Growth Rate (2015-2026)
Figure 18. Europe Erectile Dysfunction Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Erectile Dysfunction Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Erectile Dysfunction Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Erectile Dysfunction Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Erectile Dysfunction Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Erectile Dysfunction Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Erectile Dysfunction Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Erectile Dysfunction Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Erectile Dysfunction Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Erectile Dysfunction Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Erectile Dysfunction Drugs Players Market Share by Revenue in Erectile Dysfunction Drugs 2015 & 2019
Figure 29. Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Erectile Dysfunction Drugs Revenue Share by Type (2015-2020)
Figure 31. Global Erectile Dysfunction Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Erectile Dysfunction Drugs Revenue Share by Application (2015-2020)
Figure 33. Global Erectile Dysfunction Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Erectile Dysfunction Drugs Sales Market Share by Type in 2019
Figure 35. United States Erectile Dysfunction Drugs Sales Market Share by Type in 2019
Figure 36. Europe Erectile Dysfunction Drugs Sales Market Share by Company in 2019
Figure 37. Europe Erectile Dysfunction Drugs Sales Market Share by Type in 2019
Figure 38. Europe Erectile Dysfunction Drugs Sales Market Share by Application in 2019
Figure 39. China Erectile Dysfunction Drugs Sales Market Share by Company in 2019
Figure 40. China Erectile Dysfunction Drugs Sales Market Share by Type in 2019
Figure 41. China Erectile Dysfunction Drugs Sales Market Share by Application in 2019
Figure 42. Japan Erectile Dysfunction Drugs Sales Market Share by Company in 2019
Figure 43. Japan Erectile Dysfunction Drugs Sales Market Share by Type in 2019
Figure 44. Japan Erectile Dysfunction Drugs Sales Market Share by Application in 2019
Figure 45. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Company in 2019
Figure 46. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Type in 2019
Figure 47. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Application in 2019
Figure 48. India Erectile Dysfunction Drugs Sales Market Share by Company in 2019
Figure 49. India Erectile Dysfunction Drugs Sales Market Share by Type in 2019
Figure 50. India Erectile Dysfunction Drugs Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Erectile Dysfunction Drugs
Figure 53. Manufacturing Process Analysis of Erectile Dysfunction Drugs
Figure 54. Erectile Dysfunction Drugs Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
麻酔薬・鎮痛薬の世界市場レポート2020 Market Analysis and Insights: Global Anaesthetic Drugs and Pain Drugs Market The global Anaesthetic Drugs and Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anaesthetic Drugs and Pain Drugs Scope and Market …- トレプロスチニル薬の世界市場レポート2020 Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following North America, Europe are also very important market with the consumption market share of 6.8…
- 急性片頭痛治療薬の世界市場レポート2020 A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Migraine is one of the most frequent disabling neurological conditions with a major impact on the patient’s quality of life. Migraine has been described as a chronic disorder that characterized with at…
- ドライアイ治療薬の世界市場レポート2020 Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and contin…
- 副腎白質ジストロフィー治療薬の世界市場レポート2020 Adrenoleukodystrophy (ALD) is a rare, genetic, X-linked metabolic disorder caused by mutations in the ABCD1 gene that result in a deficiency in a peroxisomal protein called adrenoleukodystrophy protein (ALDP). Adrenoleukodystrophy (ALD) is a disease linked to the X chromosome. It is a result of fatt…